Literature DB >> 10218632

The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury.

A Büki1, R Siman, J Q Trojanowski, J T Povlishock.   

Abstract

In animals and man, traumatic brain injury (TBI) results in axonal injury (AI) that contributes to morbidity and mortality. Such injured axons show progressive change leading to axonal disconnection. Although several theories implicate calcium in the pathogenesis of AI, experimental studies have failed to confirm its pivotal role. To explore the contribution of Ca2+-induced proteolysis to axonal injury, this study was undertaken in an animal model of TBI employing antibodies targeting both calpain-mediated spectrin proteolysis (CMSP) and focal neurofilament compaction (NFC), a marker of intra-axonal cytoskeletal perturbation, at 15-120 minutes (min) postinjury. Light microscopy (LM) revealed that TBI consistently evoked focal, intra-axonal CMSP that was spatially and temporally correlated with NFC. These changes were seen at 15 min postinjury with significantly increasing number of axons demonstrating CMSP immunoreactivity over time postinjury. Electron microscopy (EM) demonstrated that at 15 min postinjury CMSP was confined primarily to the subaxolemmal network. With increasing survival (30-120 min) CMSP filled the axoplasm proper. These findings provide the first direct evidence for focal CMSP in the pathogenesis of generalized/diffuse AI. Importantly, they also reveal an initial subaxolemmal involvement prior to induction of a more widespread axoplasmic change indicating a spatial-temporal compartmentalization of the calcium-induced proteolytic process that may be amenable to rapid therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218632     DOI: 10.1097/00005072-199904000-00007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  67 in total

1.  Short-duration treatment with the calpain inhibitor MDL-28170 does not protect axonal transport in an in vivo model of traumatic axonal injury.

Authors:  Marek Ma; Luchuan Li; Xinran Wang; Diana L Bull; Frances S Shofer; David F Meaney; Robert W Neumar
Journal:  J Neurotrauma       Date:  2012-01-06       Impact factor: 5.269

2.  Calpastatin overexpression protects axonal transport in an in vivo model of traumatic axonal injury.

Authors:  Marek Ma; Frances S Shofer; Robert W Neumar
Journal:  J Neurotrauma       Date:  2012-08-29       Impact factor: 5.269

Review 3.  Axonal pathology in traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Exp Neurol       Date:  2012-01-20       Impact factor: 5.330

4.  A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model.

Authors:  Stephanie N Thompson; Kimberly M Carrico; Ayman G Mustafa; Mona Bains; Edward D Hall
Journal:  J Neurotrauma       Date:  2010-12       Impact factor: 5.269

5.  Ultrastructure of Diaschisis Lesions after Traumatic Brain Injury.

Authors:  Clayton A Wiley; Stephanie J Bissel; Andrew Lesniak; C Edward Dixon; Jonathan Franks; Donna Beer Stolz; Ming Sun; Guoji Wang; Robert Switzer; Patrick M Kochanek; Geoffrey Murdoch
Journal:  J Neurotrauma       Date:  2016-03-30       Impact factor: 5.269

6.  A novel strategy to activate cytoprotective genes in the injured brain.

Authors:  Jing Zhao; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Biochem Biophys Res Commun       Date:  2011-03-22       Impact factor: 3.575

Review 7.  Preconditioning for traumatic brain injury.

Authors:  Shoji Yokobori; Anna T Mazzeo; Khadil Hosein; Shyam Gajavelli; W Dalton Dietrich; M Ross Bullock
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

8.  Differential effects of FK506 on structural and functional axonal deficits after diffuse brain injury in the immature rat.

Authors:  Ann Mae Dileonardi; Jimmy W Huh; Ramesh Raghupathi
Journal:  J Neuropathol Exp Neurol       Date:  2012-11       Impact factor: 3.685

9.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

10.  THE EFFECTS OF POSTTRAUMATIC HYPOTHERMIA ON DIFFUSE AXONAL INJURY FOLLOWING PARASAGGITAL FLUID PERCUSSION BRAIN INJURY IN RATS.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  Ther Hypothermia Temp Manag       Date:  2012-03       Impact factor: 1.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.